AIDS-Related Non-Hodgkin's Lymphoma in Sub-Saharan Africa: Current Status and Realities of Therapeutic Approach
Open Access
Abstract
Today AIDS-related non-Hodgkin's lymphoma (AR-NHL) is a significant cause of morbidity and mortality in HIV-infected patients the world over, and especially in sub-Saharan Africa. While the overall incidence of AR-NHL since the emergence of combination antiretroviral therapy (cART) era has declined, the occurrence of this disease appears to have stabilized. In regions where access to cART is challenging, the impact on disease incidence is less clear. In the resource-rich environment it is clinically recognized that it is no longer appropriate to consider AR-NHL as a single disease entity and rather treatment of AIDS lymphoma needs to be tailored to lymphoma subtype. While intensive therapeutic strategies in the resource-rich world are clearly improving outcome, in AIDS epicenters of the world and especially in sub-Saharan Africa there is a paucity of data on treatment and outcomes. In fact, only one prospective study of dose-modified oral chemotherapy and limited retrospective studies with sufficient details provide a window into the natural history and clinical management of this disease. The scarcities and challenges of treatment in this setting provide a backdrop to review the current status and realities of the therapeutic approach to AR-NHL in sub-Saharan Africa. More pragmatic and risk-adapted therapeutic approaches are needed.Keywords
Funding Information
- National Institutes of Health (D43 CA153707, CA121947)
- National Institutes of Health (D43 CA153707, CA121947)
This publication has 56 references indexed in Scilit:
- Cancer Burden in the HIV-Infected Population in the United StatesJNCI: Journal of the National Cancer Institute, 2011
- Predictors of Survival After a Diagnosis of Non-Hodgkin Lymphoma in a Resource-Limited Setting: A Retrospective Study on the Impact of HIV Infection and Its TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphomaBlood, 2010
- Trimodal age‐specific incidence patterns for Burkitt lymphoma in the United States, 1973–2005International Journal of Cancer, 2010
- The Challenge of AIDS-Related Malignancies in Sub-Saharan AfricaPLOS ONE, 2010
- Quality of life, characteristics and survival of patients with HIV and lymphomaQuality of Life Research, 2010
- Dose-Modified Oral Chemotherapy in the Treatment of AIDS-Related Non-Hodgkin's Lymphoma in East AfricaJournal of Clinical Oncology, 2009
- Clinical characteristics and outcome of children with Burkitt lymphoma in Uganda according to HIV infectionPediatric Blood & Cancer, 2008
- The evidence-based treatment of AIDS-related non-Hodgkin’s lymphomaCancer Treatment Reviews, 2004
- Oral Combination Chemotherapy in the Management of AIDS-Related Lymphoproliferative MalignanciesDrugs, 1999